Satellos Bioscience Announces Results of Annual Meeting of Shareholders
<link type="text/css" rel="stylesheet" href="https://www.globenewswire.com/styles/gnw_nitf.css" /><p align="justify">TORONTO, June 17, 2026 (GLOBE NEWSWIRE) -- Satellos Bioscience Inc. (NASDAQ: MSLE, TSX: MSCL)  ("Satellos " or the "Company "), a clinical-stage biotechnology company developing life-improving medicines to treat degenerative...
Satellos Bioscience Announces Results of Annual Meeting of Shareholders
Overview
<link type="text/css" rel="stylesheet" href="https://www.globenewswire.com/styles/gnw_nitf.css" /><p align="justify">TORONTO, June 17, 2026 (GLOBE NEWSWIRE) -- Satellos Bioscience Inc. (NASDAQ: MSLE, TSX: MSCL) ("Satellos " or the "Company "), a clinical-stage biotechnology company developing life-improving medicines to treat degenerative...
Source
Originally published at markets.businessinsider.com.



